相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiovascular events, early discontinuation of trastuzumab, and their impact on survival
Shi-Yi Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Radiological assessment of breast density by visual classification (BI-RADS) compared to automated volumetric digital software (Quantra): implications for clinical practice
Elisa Regini et al.
RADIOLOGIA MEDICA (2014)
Cardioprotective Effect of β-Adrenoceptor Blockade in Patients With Breast Cancer Undergoing Chemotherapy Follow-Up Study of Heart Failure
Sinziana Seicean et al.
CIRCULATION-HEART FAILURE (2013)
Strategies to Prevent and Treat Cardiovascular Risk in Cancer Patients
Daniela Cardinale et al.
SEMINARS IN ONCOLOGY (2013)
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
K. Albain et al.
LANCET (2012)
The Utility of Cardiac Biomarkers, Tissue Velocity and Strain Imaging, and Cardiac Magnetic Resonance Imaging in Predicting Early Left Ventricular Dysfunction in Patients With Human Epidermal Growth Factor Receptor II-Positive Breast Cancer Treated With Adjuvant Trastuzumab Therapy
Nazanin Fallah-Rad et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study
Emily Ho et al.
HEART (2010)
Anthracycline-Induced Cardiomyopathy Clinical Relevance and Response to Pharmacologic Therapy
Daniela Cardinale et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Trastuzumab for Patients With Axillary-Node-Positive Breast Cancer: Results of the FNCLCC-PACS 04 Trial
Marc Spielmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
Heikki Joensuu et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the north central cancer treatment group n9831 adjuvant breast cancer trial
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
Thomas M. Suter et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
